Amikacin Inhalation; amikacin liposome inhalation suspension
Jump to navigation
Jump to search
Introduction
amikacin liposome inhalation suspension
Indications
- treatment-resistant Mycobacterium avium complex lung disease
More general terms
References
- ↑ FDA News Release. sEPT 28, 2018 FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622048.htm